Fundraising FoxSTRT — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Eveliqure develops a live attenuated vaccine platform for oral administration targeting Shigella and ETEC pathogens that cause diarrheal disease in travelers and populations in low- and middle-income countries.
BiotechHealthtechMedical Devices
Tamás Henics(Co-Founder and Chief Scientific Officer)Gábor Somogyi(Chief Executive Officer)
PartnerAndrea Kozma· solo GP
Co-investorsKinled HoldingLifelinkSmartWare.tech
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
FeelmoreMinup
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.